Search Share Prices
OptiBiotix aims for commercialisation with online store opening slated for April
UK probiotics specialist OptiBiotix Health said it is moving towards commercialisation with the planned opening of an online store in April.
The AIM traded company is targeting independent profitability and self-sustainability for each of its three divisions as it plans to take advantage of "the uniqueness of its technology" to commercialise products and food ingredients.
OptiBiotix and its partners have developed food products with the SlimBiome patented combination of natural ingredients, including biscuits, muesli pots, porridge pots, yoghurt coated fruits, and a range of cereals in puff, flakes, and crisp format.
Late-stage discussions regarding the sale of these products are ongoing with three supermarkets.
Chief executive Stephen O'Hara said: "The company believes it is making strong scientific and commercial progress across all its technology and product platforms. This has led to a number of deals with each division building a rich deal pipeline, which if successfully concluded, will lead to significant revenues in the months and years ahead."
Meanwhile, the company is optimistic for further agreements concerning its naturally occurring probiotic bacteria lactobacillus plantarum which it says can manage and prevent issues including high cholesterol, high blood pressure and glucose and energy regulation.
"Industry interest is coming from national retailers and global corporates which have potential for significant upside given the scale of their market reach. We remain on track with our strategy of building multiple revenue streams from both consumer and pharmaceutical products across all our technology platforms," said O'Hara.
As of 0942 GMT, OptiBiotix Health's shares were up 2.63% at 58.50p.